OverviewChartNewsTraderScreen

BioDelivery Sciences Internationa.../  US09060J1060  /

NASDAQ
2022-03-22  12:00:00 AM Chg. - Volume Bid- Ask- High Low
5.5900USD - 2.11 mill.
Turnover: -		 -Bid Size: - -Ask Size: - 5.6000 5.5900
GlobeNewswire 03-05 Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-10-16 Inotiv, Inc. Announces Changes to its Board Composition
GlobeNewswire 2022-03-22 Collegium Completes the Acquisition of BDSI
GlobeNewswire 2022-02-24 Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results
GlobeNewswire 2022-02-16 SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BDSI, ZWS, TSEM, MGI
GlobeNewswire 2022-02-15 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: BioDelivery...
GlobeNewswire 2022-02-14 BIODELIVERY SCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of BDSI and Encourages I...
GlobeNewswire 2022-02-14 BDSI Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Sale of BioDelivery Sciences Internatio...
GlobeNewswire 2022-02-14 Collegium to Acquire BioDelivery Sciences in an All-Cash Deal
GlobeNewswire 2022-02-14 Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio
GlobeNewswire 2022-01-20 BioDelivery Sciences Expects 2021 Revenue at the High End of Full Year Guidance
GlobeNewswire 2021-12-20 BioDelivery Sciences Prevails in BELBUCA® ANDA Litigation Maintaining Patent Exclusivity Against Alv...
GlobeNewswire 2021-11-03 BioDelivery Sciences Reports Solid Third Quarter 2021 Results
GlobeNewswire 2021-11-01 Coya Therapeutics Appoints Dr. Adrian Hepner as Chief Medical Officer and Dr. Greg MacMichael as Chi...
GlobeNewswire 2021-10-21 BioDelivery Sciences Appoints John Golubieski as Chief Financial Officer
GlobeNewswire 2021-10-20 BioDelivery Sciences to Report Third Quarter 2021 Financial Results on November 3, 2021
GlobeNewswire 2021-10-05 Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer
GlobeNewswire 2021-09-30 BioDelivery Sciences International to Host ELYXYB™ Investor Day
GlobeNewswire 2021-09-09 BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in ...
GlobeNewswire 2021-09-07 BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAIN...
GlobeNewswire 2021-09-03 BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences
GlobeNewswire 2021-08-16 AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors
GlobeNewswire 2021-08-04 BioDelivery Sciences Reports Second Quarter 2021 Results
GlobeNewswire 2021-08-04 BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™...
GlobeNewswire 2021-07-22 BioDelivery Sciences to Report Second Quarter 2021 Financial Results on August 4, 2021